Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy | Zendy

AI Assistant Blog Pricing

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.